This is What Makes Humana Inc. Stocks A Gamechanger?

Humana Inc. [HUM] stock is trading at $356.38, down -0.13%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HUM shares have gain 3.13% over the last week, with a monthly amount drifted -9.91%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Humana Inc. [NYSE: HUM] stock has seen the most recent analyst activity on June 26, 2024, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $392. Previously, Morgan Stanley started tracking the stock with Equal-Weight rating on June 24, 2024, and set its price target to $374. On April 02, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $342 on the stock. BofA Securities downgraded its rating to a Neutral. Raymond James initiated its recommendation with a Mkt Perform. Argus downgraded its rating to Hold for this stock on March 13, 2024. In a note dated March 06, 2024, Barclays initiated an Equal Weight rating and provided a target price of $356 on this stock.

Humana Inc. [HUM] stock has fluctuated between $298.61 and $530.54 over the past year. Currently, Wall Street analysts expect the stock to reach $498.37 within the next 12 months. Humana Inc. [NYSE: HUM] shares were valued at $356.38 at the most recent close of the market. An investor can expect a potential return of 39.84% based on the average HUM price forecast.

Analyzing the HUM fundamentals

Humana Inc. [NYSE:HUM] reported sales of 112.04B for the trailing twelve months, which represents a growth of 10.44%. Gross Profit Margin for this corporation currently stands at 0.88% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.1 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.7.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 354.37 points at the first support level, and at 352.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 359.48, and for the 2nd resistance point, it is at 362.57.

Ratios To Look Out For

For context, Humana Inc.’s Current Ratio is 1.66. Considering the valuation of this stock, the price to sales ratio is 0.38, the price to book ratio is 2.57 and price to earnings (TTM) ratio is 25.40.

Transactions by insiders

Recent insider trading involved Mesquita Jorge S., Director, that happened on Feb 20 ’24 when 545.0 shares were purchased.

Related Posts